NEW YORK (GenomeWeb) – Celmatix said today that it has partnered with Oncotest-Teva, a subsidiary of Teva Pharmaceutical Industries, to make Celmatix's Fertilome genetic test for reproductive health and fertility available in Israel.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.